Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7266)
All Articles published online
|
Publishing Process of This Article
|
Apr 21, 2014 (publication date) through Feb 8, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Feng QY, Wei Y, Chen JW, Chang WJ, Ye LC, Zhu DX, Xu JM. Anti-EGFR and anti-VEGF agents: Important targeted therapies of colorectal liver metastases. World J Gastroenterol 2014; 20(15): 4263-4275 [PMID: 24764664 DOI: 10.3748/wjg.v20.i15.4263] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i15/4263.htm |
| Number | Citing Articles |
| 1 |
Pasquale F. Innominato, René Adam. Use of Bevacizumab in the Management of Potentially Resectable Colorectal Liver Metastases: Safety, Pathologic Assessment and Benefit. Current Colorectal Cancer Reports 2016; 12(4): 208 doi: 10.1007/s11888-016-0326-5
|
| 2 |
Francisco Navarro Freire, Patricia Navarro Sánchez, Benito Mirón Pozo, María Teresa Delgado Ureña, José Antonio Jiménez Ríos, Pedro Antonio García López, Juan Ignacio Arcelus Martínez. Recurrence of liver metastases from colorectal cancer and repeat liver resection. Revista Española de Enfermedades Digestivas 2015; 107 doi: 10.17235/reed.2015.3843/2015
|
| 3 |
Caroline Theresa Seebauer, Stefan Brunner, Gabriel Glockzin, Pompiliu Piso, Petra Ruemmele, Hans-Juergen Schlitt, Edward Kenneth Geissler, Stefan Fichtner-Feigl, Rebecca Kesselring. Peritoneal carcinomatosis of colorectal cancer is characterized by structural and functional reorganization of the tumor microenvironment inducing senescence and proliferation arrest in cancer cells. OncoImmunology 2016; 5(12): e1242543 doi: 10.1080/2162402X.2016.1242543
|
| 4 |
Ju Seok Kim, Go Eun Bae, Seok-Hwan Kim, Min Kyung Choi, Min-Kyung Yeo. Serum-Based KRASG12/G13 Mutation Detection Using Droplet Digital PCR: Clinical Implications and Limitations in Colorectal Adenocarcinoma With Tumor Heterogeneity. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.604772
|
| 5 |
Chun-Hui Cui, Shu-Xin Huang, Jia Qi, Hui-Juan Zhu, Zong-Hai Huang, Jin-Long Yu. Neoadjuvant chemotherapy (NCT) plus targeted agents versus NCT alone in colorectal liver metastases patients: A systematic review and meta-analysis. Oncotarget 2015; 6(41): 44005 doi: 10.18632/oncotarget.5875
|
| 6 |
TOMOFUMI AKASAKA, MASAHIKO TSUJII, JUMPEI KONDO, YOSHITO HAYASHI, JIN YING, YUQUAN LU, MOTOHIKO KATO, TAKUYA YAMADA, SHUNSUKE YAMAMOTO, TAKUYA INOUE, YOSHIKI TSUJII, AKIRA MAEKAWA, TETSUJI FUJINAGA, ERI SHIRAISHI, SATOSHI HIYAMA, TAKAHIRO INOUE, SHINICHIRO SHINZAKI, KENJI WATABE, TSUTOMU NISHIDA, HIDEKI IIJIMA, TETSUO TAKEHARA. 5-FU resistance abrogates the amplified cytotoxic effects induced by inhibiting checkpoint kinase 1 in p53-mutated colon cancer cells. International Journal of Oncology 2015; 46(1): 63 doi: 10.3892/ijo.2014.2693
|
| 7 |
Kyung Ha Lee, Tae Hee Lee, Min Kyung Choi, In Sun Kwon, Go Eun Bae, Min-Kyung Yeo. Identification of a Clinical Cutoff Value for Multiplex KRASG12/G13 Mutation Detection in Colorectal Adenocarcinoma Patients Using Digital Droplet PCR, and Comparison with Sanger Sequencing and PNA Clamping Assay. Journal of Clinical Medicine 2020; 9(7): 2283 doi: 10.3390/jcm9072283
|
| 8 |
Benedikt Judmann, Diana Braun, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler. Toward the Development of GE11-Based Radioligands for Imaging of Epidermal Growth Factor Receptor-Positive Tumors. ACS Omega 2022; 7(31): 27690 doi: 10.1021/acsomega.2c03407
|
| 9 |
QIU-XIANG WU, SHUANG-XUE YUAN, CHUN-MEI REN, YU YU, WEN-JUAN SUN, BAI-CHENG HE, KE WU. Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells. Oncology Reports 2016; 35(6): 3341 doi: 10.3892/or.2016.4735
|
| 10 |
Xiaoying Qin, Honghong Luo, Yixuan Deng, Xintong Yao, Jie Zhang, Baicheng He. Resveratrol inhibits proliferation and induces apoptosis via the Hippo/YAP pathway in human colon cancer cells. Biochemical and Biophysical Research Communications 2022; 636: 197 doi: 10.1016/j.bbrc.2022.10.077
|
| 11 |
Diana Braun, Benedikt Judmann, Xia Cheng, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler. Synthesis, Radiolabeling, and In Vitro and In Vivo Characterization of Heterobivalent Peptidic Agents for Bispecific EGFR and Integrin αvβ3 Targeting. ACS Omega 2023; 8(2): 2793 doi: 10.1021/acsomega.2c07484
|
| 12 |
Alice Bartolini, Sabrina Cardaci, Simona Lamba, Daniele Oddo, Caterina Marchiò, Paola Cassoni, Carla Azzurra Amoreo, Giorgio Corti, Alessandro Testori, Federico Bussolino, Renata Pasqualini, Wadih Arap, Davide Corà, Federica Di Nicolantonio, Serena Marchiò. BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS-Mutant Colorectal Cancer. Clinical Cancer Research 2016; 22(19): 4923 doi: 10.1158/1078-0432.CCR-15-2664
|
| 13 |
Claudia Cardone, Giulia Martini, Teresa Troiani, Stefania Napolitano, Francesco Selvaggi, Fortunato Ciardiello, Erika Martinelli. Genetic Landscape of Primary Versus Metastatic Colorectal Cancer: to What Extent Are They Concordant?. Current Colorectal Cancer Reports 2015; 11(5): 217 doi: 10.1007/s11888-015-0278-1
|
| 14 |
Amna Mohamed Taha, Mohammad Mabrouk Aboulwafa, Hamdallah Zedan, Omneya Mohamed Helmy. Ramucirumab combination with sorafenib enhances the inhibitory effect of sorafenib on HepG2 cancer cells. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21582-w
|
| 15 |
Deyao Zhao, Yingyi Mo, Margarita E. Neganova, Yulia Aleksandrova, Edmund Tse, Vladimir N. Chubarev, Ruitai Fan, Olga A. Sukocheva, Junqi Liu. Dual effects of radiotherapy on tumor microenvironment and its contribution towards the development of resistance to immunotherapy in gastrointestinal and thoracic cancers. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1266537
|
| 16 |
Helen Damerow, Xia Cheng, Valeska von Kiedrowski, Ralf Schirrmacher, Björn Wängler, Gert Fricker, Carmen Wängler. Toward Optimized 89Zr-Immuno-PET: Side-by-Side Comparison of [89Zr]Zr-DFO-, [89Zr]Zr-3,4,3-(LI-1,2-HOPO)- and [89Zr]Zr-DFO*-Cetuximab for Tumor Imaging: Which Chelator Is the Most Suitable?. Pharmaceutics 2022; 14(10): 2114 doi: 10.3390/pharmaceutics14102114
|
| 17 |
Kushtrim Kryeziu, Jarle Bruun, Tormod K. Guren, Anita Sveen, Ragnhild A. Lothe. Combination therapies with HSP90 inhibitors against colorectal cancer. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2019; 1871(2): 240 doi: 10.1016/j.bbcan.2019.01.002
|
| 18 |
Benedikt Judmann, Björn Wängler, Ralf Schirrmacher, Gert Fricker, Carmen Wängler. Towards Radiolabeled EGFR-Specific Peptides: Alternatives to GE11. Pharmaceuticals 2023; 16(2): 273 doi: 10.3390/ph16020273
|
| 19 |
E Sanchez-Lopez, E Flashner-Abramson, S Shalapour, Z Zhong, K Taniguchi, A Levitzki, M Karin. Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling. Oncogene 2016; 35(20): 2634 doi: 10.1038/onc.2015.326
|
| 20 |
C. Hubert, C. Dahrenmoller, L. Marique, N. Jabbour, P. Gianello, I. Leclercq. Hepatic regeneration in a rat model is impaired by chemotherapy agents used in metastatic colorectal cancer. European Journal of Surgical Oncology (EJSO) 2015; 41(11): 1471 doi: 10.1016/j.ejso.2015.08.152
|
| 21 |
Apurva Bonde, Daniel A. Smith, Elias Kikano, Jennifer M. Yoest, Sree H. Tirumani, Nikhil H. Ramaiya. Overview of serum and tissue markers in colorectal cancer: a primer for radiologists. Abdominal Radiology 2021; 46(12): 5521 doi: 10.1007/s00261-021-03243-0
|
| 22 |
SHUANG-XUE YUAN, DONG-XU WANG, QIU-XIANG WU, CHUN-MEI REN, YANG LI, QIAN-ZHAO CHEN, YU-HUA ZENG, YING SHAO, JUN-QIN YANG, YAN BAI, PU ZHANG, YU YU, KE WU, WEN-JUAN SUN, BAI-CHENG HE. BMP9/p38 MAPK is essential for the antiproliferative effect of resveratrol on human colon cancer. Oncology Reports 2016; 35(2): 939 doi: 10.3892/or.2015.4407
|
| 23 |
Mohammad‐Javad Sanaei, Ayda Baghery Saghchy Khorasani, Atieh Pourbagheri‐Sigaroodi, Shabnam Shahrokh, Mohammad Reza Zali, Davood Bashash. The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles. Journal of Cellular Physiology 2022; 237(3): 1720 doi: 10.1002/jcp.30655
|
| 24 |
Neda Amini, Nikolaos Andreatos, Georgios Antonios Margonis, Stefan Buettner, Jaeyun Wang, Boris Galjart, Doris Wagner, Kazunari Sasaki, Anastasios Angelou, Jinger Sun, Carsten Kamphues, Andrea Beer, Daisuke Morioka, Inger Marie Løes, Efstathios Antoniou, Katsunori Imai, Emmanouil Pikoulis, Jin He, Klaus Kaczirek, George Poultsides, Cornelis Verhoef, Per Eystein Lønning, Itaru Endo, Hideo Baba, Peter Kornprat, Federico NAucejo, Martin E. Kreis, Wolfgang L. Christopher, Matthew J. Weiss, Bashar Safar, Richard Andrew Burkhart. Mutant KRAS as a prognostic biomarker after hepatectomy for rectal cancer metastases: Does the primary disease site matter?. Journal of Hepato-Biliary-Pancreatic Sciences 2022; 29(4): 417 doi: 10.1002/jhbp.1054
|
| 25 |
Nanako Hata, Kunitoshi Shigeyasu, Yuzo Umeda, Shuya Yano, Sho Takeda, Kazuhiro Yoshida, Tomokazu Fuji, Ryuichi Yoshida, Kazuya Yasui, Hibiki Umeda, Toshiaki Takahashi, Yoshitaka Kondo, Hiroyuki Kishimoto, Yoshiko Mori, Fuminori Teraishi, Hideki Yamamoto, Hiroyuki Michiue, Keiichiro Nakamura, Hiroshi Tazawa, Toshiyoshi Fujiwara. ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-29397-z
|
| 26 |
Magdalena Szaryńska, Agata Olejniczak, Jarosław Kobiela, Piotr Spychalski, Zbigniew Kmieć. Therapeutic strategies against cancer stem cells in human colorectal cancer (Review). Oncology Letters 2017; doi: 10.3892/ol.2017.7261
|
| 27 |
María González-González, María Laura Gutiérrez, José María Sayagués, Luis Muñoz-Bellvís, Alberto Orfao. Genomic profiling of sporadic liver metastatic colorectal cancer. Seminars in Cancer Biology 2021; 71: 98 doi: 10.1016/j.semcancer.2020.05.013
|
| 28 |
Yawen Dong, Jonas Santol, Birgit Gruenberger, Alfred Lenauer, Friedrich Laengle, Josef Thaler, Gudrun Piringer, Wolfgang Eisterer, Angela Djanani, Judith Stift, Thomas Gruenberger. Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers 2024; 16(5): 857 doi: 10.3390/cancers16050857
|
| 29 |
In Seon Lee, Seung Joon Choi, Cho Rong Seo, Jun Seong Kim. Comparison of the Response Evaluation Criteria in Solid Tumors with Volumetric Measurement for Evaluation of Response and Overall Survival with Liver Metastases from Colorectal Cancer. Journal of the Korean Society of Radiology 2019; 80(5): 906 doi: 10.3348/jksr.2019.80.5.906
|
| 30 |
Alessandra Tessitore, Gemma Bruera, Valentina Mastroiaco, Katia Cannita, Alessio Cortellini, Valentina Cocciolone, Antonella Dal Mas, Giuseppe Calvisi, Francesca Zazzeroni, Corrado Ficorella, Enrico Ricevuto, Edoardo Alesse. KRAS and 2 rare PI3KCA mutations coexisting in a metastatic colorectal cancer patient with aggressive and resistant disease. Human Pathology 2018; 74: 178 doi: 10.1016/j.humpath.2018.01.021
|